Cedric Edwards
Overview
Explore the profile of Cedric Edwards including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
557
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klamrowski M, Klein R, McCudden C, Green J, Rashidi B, White C, et al.
Clin J Am Soc Nephrol
. 2024 May;
PMID: 38787617
No abstract available.
2.
Hundemer G, Tangri N, Sood M, Clark E, Canney M, Edwards C, et al.
Kidney Int Rep
. 2021 Dec;
6(12):2993-3001.
PMID: 34901569
Introduction: The Kidney Failure Risk Equation (KFRE) is a clinical tool widely used to predict progression from chronic kidney disease (CKD) to kidney failure. This study aimed to evaluate the...
3.
Edwards C, Hundemer G, Petrcich W, Canney M, Knoll G, Burns K, et al.
JAMA Netw Open
. 2021 Sep;
4(9):e2123365.
PMID: 34524440
Importance: Thiazide diuretics are commonly prescribed for the treatment of hypertension, a disease highly prevalent among older individuals and in those with chronic kidney disease. How specific thiazide diuretics compare...
4.
Jegatheswaran J, Hiremath S, Edwards C, Ruzicka M
J Clin Hypertens (Greenwich)
. 2021 Jan;
22(8):1513-1517.
PMID: 33448611
The prevalence of inter-arm BP difference is high in hypertension and is associated with adverse cardiovascular outcomes. We performed a retrospective chart review of prevalent patients in the Ottawa Hospital...
5.
Hundemer G, Knoll G, Petrcich W, Hiremath S, Ruzicka M, Burns K, et al.
Am J Kidney Dis
. 2020 Sep;
77(2):178-189.e1.
PMID: 32920153
Rationale & Objectives: Alpha-blockers (ABs) are commonly prescribed for control of resistant or refractory hypertension in patients with and without chronic kidney disease (CKD). The association between AB use and...
6.
Rabi D, McBrien K, Sapir-Pichhadze R, Nakhla M, Ahmed S, Dumanski S, et al.
Can J Cardiol
. 2020 May;
36(5):596-624.
PMID: 32389335
Hypertension Canada's 2020 guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children provide comprehensive, evidence-based guidance for health care professionals and patients. Hypertension Canada...
7.
Hiremath S, Ruzicka M, Petrcich W, McCallum M, Hundemer G, Tanuseputro P, et al.
Hypertension
. 2019 Jul;
74(3):645-651.
PMID: 31327266
Alpha-blockers (ABs) are commonly prescribed as part of a multidrug regimen in the management of hypertension. We set out to assess the risk of hypotension and related adverse events with...
8.
Ruzicka M, Leenen F, Ramsay T, Bugeja A, Edwards C, McCormick B, et al.
JAMA Intern Med
. 2019 Jun;
179(10):1433-1434.
PMID: 31206124
No abstract available.
9.
Budhram B, Akbari A, Brown P, Biyani M, Knoll G, Zimmerman D, et al.
Can J Kidney Health Dis
. 2018 Jul;
5:2054358118778568.
PMID: 29977583
Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease, with afflicted patients often progressing to end-stage kidney disease (ESKD) requiring renal replacement therapy (RRT). As...
10.
Nerenberg K, Zarnke K, Leung A, Dasgupta K, Butalia S, McBrien K, et al.
Can J Cardiol
. 2018 May;
34(5):506-525.
PMID: 29731013
Hypertension Canada provides annually updated, evidence-based guidelines for the diagnosis, assessment, prevention, and treatment of hypertension in adults and children. This year, the adult and pediatric guidelines are combined in...